NCT02655952View on ClinicalTrials.gov

Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Metastatic Breast CancerMetastatic Colon CancerMetastatic Prostate Cancer
Interventions
DRUG

Foxy-5

Trial Locations (4)

2100

Clinical Research Department, Oncology, Rigshospitalet, Copenhagen

2730

Onkologisk Afdeling R, Herlev Hospital, Herlev

Unknown

Odense University Hospital, Odense

NE7 7DN

NCCC, Freeman Hospital, Newcastle

All Listed Sponsors
lead

WntResearch AB

INDUSTRY

NCT02655952 - Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients | Biotech Hunter | Biotech Hunter